Cargando…

IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report

Detalles Bibliográficos
Autores principales:	Badolato, Raffaele, Cattalini, Marco, Scaduto, Rosaria, Roversi, Sara, Galli, Jessica, Ferraro, Rosalba Monica, Cortesi, Manuela, Orcesi, Simona, Giliani, Silvia, Fazzi, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079259/ https://www.ncbi.nlm.nih.gov/pubmed/33930555 http://dx.doi.org/10.1016/j.clim.2021.108743

Ejemplares similares

Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation
por: Cattalini, Marco, et al.
Publicado: (2021)

Treatment response to Janus kinase inhibitor in a child affected by Aicardi‐Goutières syndrome
por: Galli, Jessica, et al.
Publicado: (2023)

Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis
por: Galli, Jessica, et al.
Publicado: (2018)

Family History of Autoimmune Disease in Patients with Aicardi-Goutières Syndrome
por: Schmidt, Johanna L., et al.
Publicado: (2012)

DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes
por: Giordano, Anna Maria Sole, et al.
Publicado: (2022)

Comparison between D-loop methylation and mtDNA copy number in patients with Aicardi-Goutières Syndrome
por: Dragoni, Francesca, et al.
Publicado: (2023)

MRI Features Predictive of Aicardi-Goutieres Syndrome
por: Millichap, J. Gordon
Publicado: (2015)

Aicardi–Goutières Syndrome: Brief Case Report
por: Moscote-Salazar, Luis Rafael, et al.
Publicado: (2018)

3358 Developmental Outcomes of Aicardi Goutieres Syndrome
por: Adang, Laura, et al.
Publicado: (2019)

Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib
por: Pararajasingam, Abirami, et al.
Publicado: (2022)

Characterization of Mitochondrial Alterations in Aicardi–Goutières Patients Mutated in RNASEH2A and RNASEH2B Genes
por: Dragoni, Francesca, et al.
Publicado: (2022)

Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib
por: Wang, Wei, et al.
Publicado: (2023)

Interferon-α and the calcifying microangiopathy in Aicardi–Goutières syndrome
por: Klok, Melanie D, et al.
Publicado: (2015)

Case Report: Novel Compound Heterozygous RNASEH2B Mutations Cause Aicardi–Goutières Syndrome
por: Garau, Jessica, et al.
Publicado: (2021)

Reduction of hRNase H2 activity in Aicardi–Goutières syndrome cells leads to replication stress and genome instability
por: Pizzi, Sara, et al.
Publicado: (2015)

Endocrinopathies in Aicardi Goutières syndrome—A descriptive case series
por: Worth, Chris, et al.
Publicado: (2020)

Analysis of clinical characteristics of children with Aicardi-Goutieres syndrome in China
por: Wang, Wei, et al.
Publicado: (2022)

Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review
por: Garau, Jessica, et al.
Publicado: (2019)

Hydroxychloroquine modulates immunological pathways activated by RNA:DNA hybrids in Aicardi–Goutières syndrome patients carrying RNASEH2 mutations
por: Garau, Jessica, et al.
Publicado: (2021)

Relapsing–remitting clinical course expands the phenotype of Aicardi–Goutières syndrome
por: Lambe, Jeffrey, et al.
Publicado: (2020)

Interstitial Lung Disease and Psoriasis in a Child With Aicardi-Goutières Syndrome
por: Zheng, Shaoling, et al.
Publicado: (2020)

Incidence of Aicardi-Goutières syndrome and KCNT1-related epilepsy in Denmark
por: Møller, Rikke S., et al.
Publicado: (2022)

Subacute Partially Reversible Leukoencephalopathy Expands the Aicardi–Goutières Syndrome Phenotype
por: Peixoto de Barcelos, Isabella, et al.
Publicado: (2023)

Recurrent Encephalopathy with Spinal Cord Involvement: An Atypical Manifestation of Aicardi–Goutières Syndrome
por: Samanta, Debopam, et al.
Publicado: (2019)

Aicardi-Goutières syndrome due to a paternal mosaic IFIH1 mutation
por: Tüngler, Victoria, et al.
Publicado: (2019)

Genetic Testing Contributes to Diagnosis in Cerebral Palsy: Aicardi-Goutières Syndrome as an Example
por: Beysen, Diane, et al.
Publicado: (2021)

Case Report: Aicardi-Goutières Syndrome Caused by Novel TREX1 Variants
por: Wu, De, et al.
Publicado: (2021)

Inflammatory cytokine production in a mouse model of Aicardi-Goutieres syndrome and neuroinflammation
por: Wiley, Clayton A., et al.
Publicado: (2022)

A case of Aicardi-Goutières syndrome caused by TREX1 gene mutation
por: Chenhan, Zheng, et al.
Publicado: (2023)

Aicardi–Goutières Syndrome with Congenital Glaucoma Caused by Novel TREX1 Mutation
por: Świerczyńska, Marta, et al.
Publicado: (2023)

Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi–Goutières syndrome
por: Lim, Yoong Wearn, et al.
Publicado: (2015)

RNase H2, mutated in Aicardi‐Goutières syndrome, promotes LINE‐1 retrotransposition
por: Benitez‐Guijarro, Maria, et al.
Publicado: (2018)

Cutaneous Lesions as a Clue to the Etiology of Extensive Intracranial Calcifications: Aicardi-Goutières Syndrome
por: Zeng, Yi-Heng, et al.
Publicado: (2022)

SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome
por: Takanohashi, Asako, et al.
Publicado: (2022)

Aicardi-Goutières syndrome type 7 in a Chinese child: A case report
por: Lin, Shuang-Zhu, et al.
Publicado: (2023)

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
por: Dell’Isola, Giovanni Battista, et al.
Publicado: (2023)

Modulation of LINE-1 and Alu/SVA Retrotransposition by Aicardi-Goutières Syndrome-Related SAMHD1
por: Zhao, Ke, et al.
Publicado: (2013)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Aicardi–Goutières syndrome with SAMHD1 deficiency can be diagnosed by unscheduled DNA synthesis test
por: Senju, Chikako, et al.
Publicado: (2022)

JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study
por: Frémond, Marie-Louise, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d8mjskn85h28m2oo790n7i4upk